Showing results (61-70 of 98) with videos related to
Sort By:
Pageof 10
International Journal of Hematology|December 20, 2014
Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemiaShuichi Shirane, Marito Araki, Soji Morishita, et al.Drug Metabolism and Pharmacokinetics|May 12, 2009
Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimusEriko Sato, Ikuko Yano, Masahiro Shimomura, et al.Oncology|November 20, 2017
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study GroupTomoiku Takaku, Noriyoshi Iriyama, Toru Mitsumori, et al.Case Reports in Oncology|October 30, 2024
Chromosomal Abnormalities as a Predisposition to Secondary Neurolymphomatosis in Patients with Diffuse Large B-Cell Lymphoma: A Report of Two Cases and a Literature ReviewNaoki Watanabe, Sakiko Harada, Shoko Sato, et al.The Journal of Pharmacology and Experimental Therapeutics|February 6, 2004
Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase BKokichi Suzuki, Yuko Muto, Kenichi Fushihara, et al.Drug Metabolism and Pharmacokinetics|January 16, 2007
Temporal decline in sirolimus elimination immediately after pancreatic islet transplantationEriko Sato, Masahiro Shimomura, Satohiro Masuda, et al.Biological & Pharmaceutical Bulletin|July 5, 2006
Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancerEriko Sato, Ikuko Yano, Mari Jiko, et al.International Journal of Clinical Oncology|August 19, 2007
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancersMari Jiko, Ikuko Yano, Eriko Sato, et al.Bioscience, Biotechnology, and Biochemistry|April 23, 2024
Synthesis of the A/D/E-ring Core Compounds of Maoecrystal V†Hiroki Asao, Yasuharu Shimasaki, Ayaka Sasaki, et al.Journal of the American College of Cardiology|March 26, 2003
Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemiaHirofumi Kasahara, Etsuro Tanaka, Naoto Fukuyama, et al.Pageof 10